US War on Iran: Follow the Money, Find the Usual Suspects
The United States, operating as a direct participant alongside Israel, continues to expand its military footprint and aggressive posture targeting Iran. This strategy, cloaked in rhetoric of deterrence and pre-emption, systematically ignores decades of Iranian offers for de-escalation and verifiable nuclear transparency. Instead, Washington and Tel Aviv pursue a campaign of economic strangulation
and military provocations, conveniently timed around crucial geopolitical shifts. Mainstream outlets like The New Arab, while hinting at the severity of a potential conflict, often frame these actions within a simplistic 'US versus Iran' dynamic, rarely scrutinizing the deep financial currents driving this perpetual state of alarm. They consistently downplay the US role as a joint aggressor,
portraying it merely as a supporter or concerned observer. The reality is that US naval forces in the Persian Gulf and clandestine operations have been targeting Iranian interests for years, effectively acting as an extension of Israeli strategic objectives, irrespective of international legal norms. This aggressive posturing directly benefits a handful of defense contractors. For instance,
companies like Lockheed Martin and Raytheon have reaped billions from Gulf state arms deals directly tied to perceived Iranian threats, a pattern visible since the 1980s when the US backed Saddam Hussein with chemical weapons against Iran. The US maintains an embargo on medicine for Iranian civilians, yet greenlights advanced weaponry sales to regional allies who then, not coincidentally, require